Anagnostics
Pioneering systems and tests for research and clinical in-vitro diagnostics to address unmet needs in protein and infectious disease diagnostics.
Pioneering systems and tests for research and clinical in-vitro diagnostics to address unmet needs in protein and infectious disease diagnostics.
Anagnostics is a pioneering company specializing in developing systems and tests for research and clinical in-vitro diagnostics. Established in 2005, the company focuses on addressing unmet needs, particularly in protein and infectious disease diagnostics. Anagnostics aims to provide innovative solutions in the biotechnology and healthcare industries through its cutting-edge technologies. The company received a significant €3.79M Venture Round investment from Tecnet Equity and PP Capital on 27th February 2009, showcasing investor confidence in the company's potential for growth and impact in the diagnostics field.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | €3.79M | 2 |
|
27 Feb 2009 |
| Venture Round | Unknown | 1 | tech2b Inkubator | 01 Jan 2003 |
No recent news or press coverage available for Anagnostics.
We care about your data, and we'd love to use cookies make your experience better.
